News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
701,598 Results
Type
Article (40073)
Company Profile (271)
Press Release (661254)
Multimedia
Podcasts (52)
Webinars (12)
Section
Business (205088)
Career Advice (2020)
Deals (35531)
Drug Delivery (97)
Drug Development (81240)
Employer Resources (172)
FDA (16210)
Job Trends (14913)
News (346454)
Policy (32647)
Tag
Academia (2572)
Accelerated approval (5)
Adcomms (20)
Allergies (85)
Alliances (49776)
ALS (88)
Alzheimer's disease (1384)
Antibody-drug conjugate (ADC) (127)
Approvals (16215)
Artificial intelligence (253)
Autoimmune disease (22)
Automation (16)
Bankruptcy (363)
Best Places to Work (11658)
BIOSECURE Act (20)
Biosimilars (106)
Biotechnology (190)
Bladder cancer (78)
Brain cancer (27)
Breast cancer (279)
Cancer (2257)
Cardiovascular disease (173)
Career advice (1688)
Career pathing (30)
CAR-T (152)
Cell therapy (427)
Cervical cancer (19)
Clinical research (66107)
Collaboration (841)
Compensation (524)
Complete response letters (19)
COVID-19 (2604)
CRISPR (41)
C-suite (242)
Cystic fibrosis (100)
Data (2197)
Decentralized trials (2)
Denatured (20)
Depression (42)
Diabetes (271)
Diagnostics (6388)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (120)
Drug pricing (100)
Drug shortages (25)
Duchenne muscular dystrophy (93)
Earnings (86731)
Editorial (36)
Employer branding (21)
Employer resources (146)
Events (112877)
Executive appointments (729)
FDA (17459)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (752)
Gene editing (106)
Generative AI (19)
Gene therapy (302)
GLP-1 (711)
Government (4429)
Grass and pollen (4)
Guidances (59)
Healthcare (18834)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (119)
Indications (29)
Infectious disease (2747)
Inflammatory bowel disease (140)
Inflation Reduction Act (10)
Influenza (51)
Intellectual property (96)
Interviews (311)
IPO (16540)
IRA (42)
Job creations (3665)
Job search strategy (1434)
Kidney cancer (10)
Labor market (38)
Layoffs (474)
Leadership (17)
Legal (7944)
Liver cancer (75)
Lung cancer (320)
Lymphoma (153)
Machine learning (7)
Management (58)
Manufacturing (304)
MASH (66)
Medical device (13386)
Medtech (13391)
Mergers & acquisitions (19533)
Metabolic disorders (684)
Multiple sclerosis (80)
NASH (16)
Neurodegenerative disease (89)
Neuropsychiatric disorders (27)
Neuroscience (1919)
NextGen: Class of 2025 (6548)
Non-profit (4491)
Now hiring (39)
Obesity (362)
Opinion (208)
Ovarian cancer (75)
Pain (86)
Pancreatic cancer (84)
Parkinson's disease (148)
Partnered (21)
Patents (233)
Patient recruitment (110)
Peanut (46)
People (57625)
Pharmaceutical (67)
Pharmacy benefit managers (18)
Phase I (20611)
Phase II (29118)
Phase III (21680)
Pipeline (1184)
Policy (141)
Postmarket research (2564)
Preclinical (8772)
Press Release (64)
Prostate cancer (106)
Psychedelics (30)
Radiopharmaceuticals (246)
Rare diseases (378)
Real estate (5953)
Recruiting (65)
Regulatory (22338)
Reports (46)
Research institute (2327)
Resumes & cover letters (350)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (68)
Series A (132)
Series B (84)
Service/supplier (13)
Sickle cell disease (52)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3629)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (39)
The Weekly (30)
Vaccines (687)
Venture capitalists (43)
Weight loss (235)
Women's health (35)
Worklife (16)
Date
Today (174)
Last 7 days (877)
Last 30 days (2642)
Last 365 days (32936)
2025 (10640)
2024 (35330)
2023 (40179)
2022 (51287)
2021 (55834)
2020 (54153)
2019 (46641)
2018 (35123)
2017 (32222)
2016 (31629)
2015 (37706)
2014 (31454)
2013 (26499)
2012 (28770)
2011 (29426)
2010 (27525)
Location
Africa (721)
Alabama (53)
Alaska (7)
Arizona (231)
Arkansas (13)
Asia (38045)
Australia (6232)
California (6124)
Canada (2009)
China (521)
Colorado (267)
Connecticut (272)
Delaware (146)
Europe (81738)
Florida (907)
Georgia (205)
Idaho (58)
Illinois (537)
India (26)
Indiana (307)
Iowa (11)
Japan (161)
Kansas (105)
Kentucky (23)
Louisiana (10)
Maine (62)
Maryland (888)
Massachusetts (4566)
Michigan (219)
Minnesota (390)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (63)
New Hampshire (64)
New Jersey (1721)
New Mexico (28)
New York (1738)
North Carolina (965)
North Dakota (8)
Northern California (2672)
Ohio (205)
Oklahoma (14)
Oregon (35)
Pennsylvania (1373)
Puerto Rico (12)
Rhode Island (33)
South America (1099)
South Carolina (22)
South Dakota (1)
Southern California (2300)
Tennessee (101)
Texas (909)
United States (23086)
Utah (180)
Virginia (145)
Washington D.C. (62)
Washington State (554)
West Virginia (3)
Wisconsin (54)
701,598 Results for "alamar biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Alamar Biosciences Announces the Launch of the NULISAseq Mouse Panel 120
March 25, 2025
·
2 min read
Press Releases
Alamar Biosciences Announces First Five Distribution Partners, Expanding Commercial Support in Asia Pacific
March 19, 2025
·
1 min read
Press Releases
Alamar Biosciences Unveils NULISAseq Inflammation Panel AQ
January 22, 2025
·
2 min read
Press Releases
Alamar Biosciences Launches Certified Service Provider Program to Expand Access to NULISA technology for Academic and Biopharmaceutical Researchers
February 21, 2025
·
2 min read
Press Releases
Alzheimer’s Drug Discovery Foundation’s Diagnostics Accelerator (DxA) invests $10M in Alamar Biosciences, Inc. to Advance Precision Medicine in Alzheimer’s Disease
January 8, 2025
·
5 min read
Business
Alamar Biosciences and Biomarkers of Aging Consortium Join Forces to Revolutionize Longevity Research
Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease in collaboration with the Biomarkers of Aging Consortium announced the launch of the next phase of the Biomarkers of Aging Challenge Series.
June 27, 2024
·
3 min read
Business
Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research
Biognosys and Alamar Biosciences, Inc. are pleased to announce a strategic partnership aimed at advancing scientific discovery in the field of biofluid proteomics biomarkers.
April 4, 2024
·
5 min read
Press Releases
Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators
January 15, 2025
·
4 min read
Press Releases
ESYA Labs Partners with Alamar Biosciences to Advance Biomarker Detection and Diagnostics for Neurological Diseases
December 4, 2024
·
2 min read
Business
Alamar Biosciences and ALZpath, Inc. Announce Strategic Supply Agreement for pTau217 Antibody to Advance Alzheimer’s Disease Research
Alamar Biosciences is pleased to announce a strategic supply agreement with ALZpath, a leading developer of diagnostic solutions in Alzheimer’s disease and related dementias.
February 29, 2024
·
3 min read
1 of 70,160
Next
